îæ€çŽ¢
îæ€çŽ¢
î
Ultragenyx Pharmaceutical Inc
RAREîãŠã©ãããªã¹ãã«è¿œå
24.910USD
-1.130-4.34%
çµå€Â 07-31 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
2.45Bæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-07-31Ultragenyx Pharmaceutical Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.42ã§ãå»è¬åæ¥çã§ã¯155瀟äž36äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯78.50ã§ãæé«ã¯128.00ãæäœã¯35.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
19
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
52.056
ç®æšæ ªäŸ¡
+108.97%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
160
åèš
6
äžå€®å€
9
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Ultragenyx Pharmaceutical Inc
RARE
19
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
32
Pfizer Inc
PFE
32
1
2
3
...
32
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
Ultragenyx Pharmaceutical Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îUltragenyx Pharmaceutical Inc ã®äºæ³åç㯠180.24M ã§ãã
Ultragenyx Pharmaceutical Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãUltragenyx Pharmaceutical Inc ã®ç®æšæ ªäŸ¡ã USD 78.50 ãšäºæ³ããæé«äºæ³ã¯ USD 128.00ãæäœäºæ³ã¯ USD 35.00 ãšäºæ³ããŠããŸãã
Ultragenyx Pharmaceutical IncRARE ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -1.84 ã§ããããUltragenyx Pharmaceutical IncRARE ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -1.29 ã§ããã次ã®ååæã® EPS 㯠USD -1.23 ãšäºæ³ãããŸãã
Ultragenyx Pharmaceutical Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î19 ã¢ããªã¹ãã«ãã Ultragenyx Pharmaceutical Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Ultragenyx Pharmaceutical Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã